{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"Niuerli Capital","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"纽尔利资本是中国本土早期风险投资机构，深耕初创团队与早期公司。","sources":[],"related":[{"id":"f6faa94b-ac7b-488d-9432-df41acc518b5","kind":"news","code":"f6faa94b-ac7b-488d-9432-df41acc518b5","name":"Aureka Biotechnologies raises USD 35 million in Series A+ financing","nameBasis":"translated-title","summary":"On 2026-04-28, according to Xiniu Data, Aureka Biotechnologies completed Series A+ financing, raising USD 35 million. Investors were lead investor Hongshan China, Jingwei Venture Capital, Boyuan Capital, Wuyuan Capital and others. The company is a developer of antibody drugs using generative AI.","description":"","country":null,"category":null,"originalName":"Aureka Biotechnologies完成A+轮融资，金额3500万美元","eventDate":"2026-04-28T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:18:20.521Z","englishUpdatedAt":"2026-10-15T19:46:04.347Z","reviewedAt":"2026-10-15T19:46:04.347Z","snapshotAt":"2026-10-15T18:31:34.288Z","sourceHash":"b55abebf368008b4cc6e0682111fe0d2950a93307d7321034921e70cb6e7dcbf","companyId":"45d3d734-4612-4acd-93a4-8687ab7e94ca","foundedYear":null,"logoUrl":null,"path":"/news/f6faa94b-ac7b-488d-9432-df41acc518b5"},{"id":"92b2de7e-1b71-444b-81d1-7b560c8913c6","kind":"news","code":"92b2de7e-1b71-444b-81d1-7b560c8913c6","name":"Aureka Biotechnologies raises tens of millions of USD in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Aureka Biotechnologies完成数千万美元A轮融资","eventDate":"2025-11-10T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-13T16:57:22.821Z","englishUpdatedAt":"2026-10-15T17:19:59.743Z","reviewedAt":"2026-10-15T17:19:59.743Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"84a2442c0dfa60900e3229f90f9e51cbbad2e0c9ea0eeff3049c3598a94b0821","companyId":"45d3d734-4612-4acd-93a4-8687ab7e94ca","foundedYear":null,"logoUrl":null,"path":"/news/92b2de7e-1b71-444b-81d1-7b560c8913c6"},{"id":"3cf52c95-d578-4c3c-ad48-9b19ff63a715","kind":"news","code":"3cf52c95-d578-4c3c-ad48-9b19ff63a715","name":"Xunming Shengke raises USD 100 million in Series B funding, bringing total funding close to USD 200 million","nameBasis":"translated-title","summary":"On 2026/8/11, Elsewhere reported that Chinese biological AI company Xunming Shengke raised USD 100 million in Series B funding, bringing total funding close to USD 200 million. The round was completed in stages, with proceeds supporting biological foundation model R&D and training at scale.","description":"","country":null,"category":null,"originalName":"寻明生科完成1亿美元B轮融资，累计融资近2亿美元","eventDate":"2026-08-11T00:00:00.000Z","website":"https://elsewhere.news/zh/5ycapital/1bai-5y-news","sourceUpdatedAt":"2026-10-10T18:51:56.028Z","englishUpdatedAt":"2026-10-15T22:57:45.271Z","reviewedAt":"2026-10-15T22:57:45.271Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"83e8ff58f98fdcea31f38305af1baa130c41b3da7535ac77e8d4463aa01e6191","companyId":"45d3d734-4612-4acd-93a4-8687ab7e94ca","foundedYear":null,"logoUrl":null,"path":"/news/3cf52c95-d578-4c3c-ad48-9b19ff63a715"}],"path":"/institutions/niuerli-capital","displayName":"纽尔利资本","displayNameLang":"zh","structured":{"city":null,"country":"China (mainland)","location":null,"role":null,"category":null,"company":null},"definition":"纽尔利资本 is a venture capital investor based in China (mainland) with 3 recorded investments.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/niuerli-capital"}